CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

    Related Conference of CRISPR Based Technologies and Bio-products

    June 08-08, 2022

    15th World Conference on Human Genomics and Genomic Medicine

    Singapore City, Singapore
    June 08-08, 2022

    9th World Congress on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 23-23, 2022

    9th World Congress on Epigenetics and Chromosome

    Barcelona, Spain
    July 11-12, 2022

    26th Global Congress on Biotechnology

    Vienna, Austria
    August 25-25, 2022

    7th International Conference on Molecular Medicine and Diagnostics

    Singapore City, Singapore
    September 19-20, 2022

    International Summit on Genomics and Proteomics

    Dublin, Ireland
    September 19-20, 2022

    15th World Congress on Stem Cell Research

    Dublin, Ireland
    October 17-18, 2022

    21st International Conference on Structural Biology

    Barcelona, Spain
    November 21-22, 2022

    4th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in